Akemi Ryu
Impact in
- Immunology top 2%
- Galectins and Cancer Biology
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
-
- Skin Protection and Aging 3
- Acne and Rosacea Treatments and Effects 2
-
- Fullerene Chemistry and Applications 3
- Co-authors
- Kumi Arakane (9 shared papers)Tetsuo Nagano (8 shared papers)Laurent Monney (2 shared papers)Edward Greenfield (2 shared papers)Gordon J. Freeman (2 shared papers)Vijay K. Kuchroo (2 shared papers)Tatyana Chernova (1 shared paper)Stephen Manning (1 shared paper)
- Journals
- Chemical and Pharmaceutical Bulletin (3 papers)Alternatives to Laboratory Animals (2 papers)The Journal of Immunology (1 paper)Biochemical and Biophysical Research Communications (1 paper)Biological and Pharmaceutical Bulletin (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Akemi Ryu
19 papers receiving 2.6k citations
Akemi Ryu's Hit Papers
Peers
Comparison fields: 5 of 138
- Immunology 1.1k
- Oncology 561
- Organic Chemistry 487
- Dermatology 123
- Materials Chemistry 629
Countries citing papers authored by Akemi Ryu
This map shows the geographic impact of Akemi Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akemi Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akemi Ryu more than expected).
Fields of papers citing papers by Akemi Ryu
This network shows the impact of papers produced by Akemi Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akemi Ryu. The network helps show where Akemi Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Akemi Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease Hit paper breakdown → | 2002 | 1393 |
| 2 | Active Oxygen Species Generated from Photoexcited Fullerene (C60) as Potential Medicines: O2-•versus1O2 Hit paper breakdown → | 2003 | 630 |
| 3 | 1997 | 133 | |
| 4 | 1997 | 99 | |
| 5 | 1996 | 93 | |
| 6 | 1995 | 91 | |
| 7 | 1994 | 67 | |
| 8 | 2009 | 39 | |
| 9 | 1996 | 28 | |
| 10 | 2002 | 27 | |
| 11 | 2007 | 26 | |
| 12 | 1998 | 26 | |
| 13 | 1997 | 25 | |
| 14 | 2020 | 12 | |
| 15 | 2000 | 9 | |
| 16 | 1999 | 4 | |
| 17 | 1999 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2019 | 3 |
About Akemi Ryu
Akemi Ryu is a scholar working on Dermatology, Organic Chemistry, Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 19 papers that have together received 2.7k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (3 papers), melanin and skin pigmentation (3 papers), Skin Protection and Aging (3 papers), Fullerene Chemistry and Applications (3 papers), Galectins and Cancer Biology (2 papers), Immune Cell Function and Interaction (2 papers), Acne and Rosacea Treatments and Effects (2 papers) and Animal testing and alternatives (2 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (561 citations), Organic Chemistry (487 citations), Dermatology (123 citations) and Materials Chemistry (629 citations). Akemi Ryu has collaborated with scholars based in Japan and United States. Frequent co-authors include Kumi Arakane, Tetsuo Nagano, Laurent Monney, Edward Greenfield, Gordon J. Freeman, Vijay K. Kuchroo, Tatyana Chernova, Stephen Manning, Hanspeter Waldner and Catherine A. Sabatos. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Alternatives to Laboratory Animals, The Journal of Immunology, Biochemical and Biophysical Research Communications and Biological and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.